Have specific questions?
Talk with Expert
Executive Director, Global Project Management, Neuroscience, Neurology Franchise Lead,
Over 20 Years' Experience
Anne-Claude Muratet has more than 20 years of clinical research experience at both CRO and pharmaceutical companies. In the past 15 years, her focus was centred around oversight strategy and management of global programs, line management, and business development activities.
Ms. Muratet’s experience includes a variety of indications in psychiatry and neurology (multiple sclerosis, acute ischemic stroke, agitation in Alzheimer’s disease patients, epilepsy, schizophrenia, major depressive disorder, generalised anxiety disorder, sleep, and neuropathic pain) as well as several other indications in rare diseases, spanning the full spectrum of activities and services in Phase I to Phase IV studies and programs.
Ms. Muratet has contributed to the successful development of the EMA registration dossier of a novel antidepressant. Over the last few years, she directed a large pivotal program of seven studies in Phase II and Phase III in schizophrenia and served as the customer Portfolio Lead within a strategic partnership in multiple sclerosis, providing operational strategy for the development plan and overseeing the delivery of clinical programs for several compounds in multiple sclerosis, as well as in other indications.
Ms. Muratet’s current responsibilities include responsibility for the overall management of Worldwide’s project management team in neurology indications globally, to ensure excellence in the delivery and quality of programs. This involves line management of project management staff, project oversight, and liaising with customers. Ms. Muratet holds a PharmD from the University of Lille, France.